This study evaluates tolerability and efficacy of a nanosilicon-based spray formula in 34 patients with mild and/or moderate atopic dermatitis. A marked improvement of the symptoms was achieved in 85% of cases, and an unremarkable one in 15% of cases. The product was always well tolerated and never caused side effects.
|Number of pages||4|
|Journal||European Journal of Pediatric Dermatology|
|Publication status||Published - 2008|
- Atopic dermatitis
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health